Upside | ||||||
---|---|---|---|---|---|---|
TMO | 7.31% | aa.aa | 405.20 | +2.93% | 826 | |
NVZMY | 5.54% | aa.aa | 70.82 | +1.53% | 4,140 | |
CTVA | 5.54% | aa.aa | 70.28 | +1.77% | 4,332 | |
ABBV | 5.39% | aa.aa | 185.39 | +1.16% | 1,340 | |
BIO | 5.12% | aa.aa | 229.50 | +2.56% | 1,018 | |
LLY | 4.62% | aa.aa | 728.60 | +2.09% | 249 | |
ASND | 4.45% | aa.aa | 158.19 | -2.35% | 1,267 | |
AZN | 4.36% | aa.aa | 70.97 | +0.80% | 2,943 | |
NVDA | 3.80% | aa.aa | 135.41 | +3.14% | 1,692 | |
CDNS | 3.73% | aa.aa | 322.88 | +2.34% | 607 |
Putnam ETF Trust - Putnam BioRevolution ETF is an exchange traded fund launched and managed by Putnam Investment Management, LLC. The fund is co-managed by Putnam Investments Limited. It invests in the public equity markets of global region. It invests in stocks of companies operating across healthcare, pharmaceuticals, biotechnology, life sciences and biology revolution sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to benchmark the performance of its portfolio against the S&P 500 Index. Putnam ETF Trust - Putnam BioRevolution ETF was formed on September 29, 2022 and is domiciled in the United States.